Table 1. A single immunization with recombinant adenovirus encoding vaccinia virus glycoprotein A27L elicits complete protection against a virulent respiratory poxvirus infection.
A33R | Forward 5′- CACCGGATCCATGATGACACCAGAAAACGACGAAG -3′ (BamHI) Reverse 5′- GAATTCTTAGTTCATTGTTTTAACAC -3′ (EcoRI) |
A34R | Forward 5′- CACCGGATCCATGAAATCGCTTAATAGACAAACTG -3′ (BamHI) Reverse 5′- GAATTCTCACTTGTAGAATTTTTTAACAC -3′ (EcoRI) |
A36R | Forward 5′- CACCGGATCCATGATGCTGGTACCTCTTATCACG -3′ (BamHI) Reverse 5′- GAATTCTCACACCAATGATACGACCGATG -3′ (EcoRI) |
B5R | Forward 5′- CACCAGATCTATGAAAACGATTTCCGTTGTTACG -3′ (BgIII) Reverse 5′- CTGCAGTTACGGTAGCAATTTATGGAAC -3′ (PstI) |
A27L | Forward 5′- CACCATGGGATCCATGGACGGAACTC -3′ (BamHI) Reverse 5′- GAATTCTTACTCATATGGACGCCGTC -3′ (EcoRI) |
L1R | Forward 5′- CACCATGGGATCCATGGGTGCCGCAC -3′ (BamHI) Reverse 5′- GAATTCTCAGTTTTGCATATCCGTGG -3′ (EcoRI) |
Primer sequences for the vaccinia virus proteins used for PCR amplification with highlighted “CACC” sequences and underlined restriction enzyme sites